How the ageing microenvironment influences tumour progression

[1]  S. Stewart,et al.  Unmasking senescence: context-dependent effects of SASP in cancer , 2019, Nature Reviews Cancer.

[2]  R. Westendorp,et al.  Are skin senescence and immunosenescence linked within individuals? , 2019, Aging cell.

[3]  J. DeGregori,et al.  A generalized theory of age-dependent carcinogenesis , 2019, eLife.

[4]  G. David,et al.  Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role , 2019, Molecular and Cellular Biology.

[5]  A. Alimonti,et al.  Cellular Senescence: Aging, Cancer, and Injury. , 2019, Physiological reviews.

[6]  E. Hibler,et al.  The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma , 2019, Front. Pharmacol..

[7]  A. Sabnis,et al.  Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology. , 2019, Trends in molecular medicine.

[8]  Mark M. Davis,et al.  A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring , 2019, Nature Medicine.

[9]  A. Muzikansky,et al.  Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Richard T. Lee,et al.  Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. , 2019, Journal of molecular and cellular cardiology.

[11]  Shengjun Wang,et al.  MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation , 2019, Front. Immunol..

[12]  J. Boeke,et al.  LINE-1 derepression in senescent cells triggers interferon and inflammaging , 2018, Nature.

[13]  A. R. Fernandes,et al.  Targeting Tumor Microenvironment for Cancer Therapy , 2019, International journal of molecular sciences.

[14]  Richard T. Lee,et al.  IL-33/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation , 2019, Proceedings of the National Academy of Sciences.

[15]  J. Parker,et al.  Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence , 2019, Proceedings of the National Academy of Sciences.

[16]  Soyoung Lee,et al.  The dynamic nature of senescence in cancer , 2019, Nature Cell Biology.

[17]  W. Willett,et al.  Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women , 2019, JAMA oncology.

[18]  Camille Stephan-Otto Attolini,et al.  Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging , 2018, Cell.

[19]  V. Greco,et al.  Positional Stability and Membrane Occupancy Define Skin Fibroblast Homeostasis In Vivo , 2018, Cell.

[20]  Stephen M. Douglass,et al.  Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma , 2018, Pigment cell & melanoma research.

[21]  S. Pitson,et al.  The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity , 2018, Front. Oncol..

[22]  Stephen M. Douglass,et al.  Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis. , 2018, Cancer discovery.

[23]  Stephen M. Douglass,et al.  Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. , 2018, Cancer discovery.

[24]  A. E. del Río Hernández,et al.  Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.

[25]  S. Walmsley,et al.  The role of neutrophils in cancer , 2018, British medical bulletin.

[26]  K. Hartshorn,et al.  Aging, immune senescence, and immunotherapy: A comprehensive review. , 2018, Seminars in oncology.

[27]  T. Curiel,et al.  Considerations for successful cancer immunotherapy in aged hosts , 2018, Experimental Gerontology.

[28]  S. Barry,et al.  IL-23 secreted by myeloid cells drives castration-resistant prostate cancer , 2018, Nature.

[29]  Stephen M. Douglass,et al.  Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations , 2018, Clinical Cancer Research.

[30]  E. Shevach.  Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study , 2018, Front. Immunol..

[31]  A. Romano,et al.  PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy , 2018, Expert review of molecular diagnostics.

[32]  H. Cohen,et al.  Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) , 2018, The oncologist.

[33]  J. Grillari,et al.  Cellular Senescence and Inflammaging in Age-Related Diseases , 2018, Mediators of inflammation.

[34]  Y. Taniyama,et al.  IGF Binding Protein-5 Induces Cell Senescence , 2018, Front. Endocrinol..

[35]  A. Stolzing,et al.  Cellular senescence: Immunosurveillance and future immunotherapy , 2018, Ageing Research Reviews.

[36]  T. Casale,et al.  Age-Related Increase Of IL-33 In Non-Eosinophilic Nasal Polyps , 2018 .

[37]  F. Nicoletti,et al.  Ageing: from inflammation to cancer , 2018, Immunity & Ageing.

[38]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[39]  Junqian Zhang,et al.  Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade , 2018, eLife.

[40]  A. Cohen,et al.  Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? , 2018, Front. Immunol..

[41]  J. Gil,et al.  Senescence and aging: Causes, consequences, and therapeutic avenues , 2018, The Journal of cell biology.

[42]  M. Serrano,et al.  Senescence promotes in vivo reprogramming through p16INK 4a and IL‐6 , 2017, Aging cell.

[43]  A. Pourfathollah,et al.  Evaluation of age effects on doxorubicin-induced toxicity in mesenchymal stem cells , 2017, Medical journal of the Islamic Republic of Iran.

[44]  M. Schosserer,et al.  The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy , 2017, Front. Oncol..

[45]  V. Weaver,et al.  Tissue Force Programs Cell Fate and Tumor Aggression. , 2017, Cancer discovery.

[46]  B. Blomberg,et al.  Age-associated B cells (ABC) inhibit B lymphopoiesis and alter antibody repertoires in old age. , 2017, Cellular immunology.

[47]  T. Minamino,et al.  Angiogenesis, Cancer, and Vascular Aging , 2017, Front. Cardiovasc. Med..

[48]  M. Zaidi,et al.  TAMeless traitors: macrophages in cancer progression and metastasis , 2017, British Journal of Cancer.

[49]  F. Tas,et al.  Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival. , 2017, Molecular and clinical oncology.

[50]  E. Mavrogonatou,et al.  Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[51]  W. Cho,et al.  Cancer and Aging - the Inflammatory Connection , 2017, Aging and disease.

[52]  Kjetil Søreide,et al.  The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks , 2017, Aging and disease.

[53]  Tianxiang Chen,et al.  Age-related Impairment of Vascular Structure and Functions , 2017, Aging and disease.

[54]  Johannes Griss,et al.  Tumor-associated B-cells induce tumor heterogeneity and therapy resistance , 2017, Nature Communications.

[55]  Ting Huang,et al.  Stem cells in cancer therapy: opportunities and challenges , 2017, Oncotarget.

[56]  A. Giobbie-Hurder,et al.  Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma. , 2017, The oncologist.

[57]  R. Faragher,et al.  Senescence in the aging process , 2017, F1000Research.

[58]  H. Schiller,et al.  The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease , 2017, European Respiratory Journal.

[59]  R. DuBois,et al.  CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. , 2017, Cancer research.

[60]  Shenghui He,et al.  Senescence in Health and Disease , 2017, Cell.

[61]  L. Fashoyin-Aje,et al.  FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration. , 2017 .

[62]  G. Lima,et al.  Immunosenescence in testicular cancer survivors treated with chemotherapy. , 2017 .

[63]  T. Karantanos,et al.  Immunotherapy comes of age: Immune aging & checkpoint inhibitors. , 2017, Journal of geriatric oncology.

[64]  J. Elisseeff,et al.  Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment , 2017, Nature Medicine.

[65]  Brian A. Aguado,et al.  Engineering the pre-metastatic niche , 2017, Nature Biomedical Engineering.

[66]  T. Curiel,et al.  Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors. , 2017, Cancer research.

[67]  Denis Wirtz,et al.  Modeling the two-way feedback between contractility and matrix realignment reveals a nonlinear mode of cancer cell invasion , 2017, Proceedings of the National Academy of Sciences.

[68]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[69]  B. Kennedy,et al.  Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. , 2017, Cancer discovery.

[70]  T. Curiel,et al.  Considerations for successful cancer immunotherapy in aged hosts , 2017, Clinical and experimental immunology.

[71]  A. Ravaud,et al.  Targeted therapy and elderly people: A review. , 2016, European journal of cancer.

[72]  M. Blasco,et al.  Tissue damage and senescence provide critical signals for cellular reprogramming in vivo , 2016, Science.

[73]  A. Weeraratna,et al.  In the Wnt-er of life: Wnt signalling in melanoma and ageing , 2016, British Journal of Cancer.

[74]  Rulla M Tamimi,et al.  Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  T. Hsu.  Educational initiatives in geriatric oncology - Who, why, and how? , 2016, Journal of geriatric oncology.

[76]  J. Parker,et al.  Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging , 2016, EBioMedicine.

[77]  D. Saur,et al.  RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. , 2016, The Journal of clinical investigation.

[78]  U. Galderisi,et al.  Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses , 2016, Aging.

[79]  Jingqin Luo,et al.  Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis , 2016, Nature Communications.

[80]  R. Pazdur,et al.  FDA subset analysis of the safety of nivolumab in elderly patients with advanced cancers. , 2016 .

[81]  J. Wolchok,et al.  Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80 , 2016 .

[82]  Pallav Sengupta,et al.  Men and mice: Relating their ages. , 2016, Life sciences.

[83]  T. Curiel,et al.  Age and sex affect αCTLA-4 efficacy alone and combined with αB7-H1 or regulatory T cell depletion in a melanoma model. , 2016, The Journal of Immunology.

[84]  S. Y. Lim,et al.  Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis , 2016, Cancer Microenvironment.

[85]  L. Ferrucci,et al.  sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.

[86]  C. Livi,et al.  Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[87]  S. Stewart,et al.  Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development. , 2016, Cell reports.

[88]  I. Bautmans,et al.  Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study , 2015, BMC Cancer.

[89]  R. Loeser,et al.  Aging-related inflammation in osteoarthritis. , 2015, Osteoarthritis and cartilage.

[90]  Catherine C. Park,et al.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[91]  S. Gettinger,et al.  3094 Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC) , 2015 .

[92]  T. Curiel,et al.  Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice , 2015, Aging cell.

[93]  H. Nelson,et al.  Young Age and Aggressive Treatment in Colon Cancer. , 2015, JAMA.

[94]  Guillaume Lamour,et al.  Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications* , 2015, The Journal of Biological Chemistry.

[95]  Mohamed Hassan,et al.  Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target , 2015, Front. Oncol..

[96]  O. Gluz,et al.  The prognostic impact of age in different molecular subtypes of breast cancer , 2015, Breast Cancer Research and Treatment.

[97]  M. Karin,et al.  Immune Infiltration and Prostate Cancer , 2015, Front. Oncol..

[98]  G. Linette,et al.  Clinical response, progression-free survival (PFS), and safety in patients (pts) with advanced melanoma (MEL) receiving nivolumab (NIVO) combined with ipilimumab (IPI) vs IPI monotherapy in CheckMate 069 study. , 2015 .

[99]  Y. Ben-Neriah,et al.  Senescence-associated inflammatory responses: aging and cancer perspectives. , 2015, Trends in immunology.

[100]  D. Fitzgerald,et al.  Ageing and the immune system: focus on macrophages. , 2015, European journal of microbiology & immunology.

[101]  R. Faragher,et al.  Cellular senescence: from growth arrest to immunogenic conversion , 2015, AGE.

[102]  M. Oren,et al.  Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy , 2015, Cell Death and Differentiation.

[103]  A. Weeraratna,et al.  Wnt5A promotes an adaptive, senescent‐like stress response, while continuing to drive invasion in melanoma cells , 2015, Pigment cell & melanoma research.

[104]  I. Bautmans,et al.  Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer. , 2015, Anticancer research.

[105]  A. Grigorescu,et al.  Journal of Translational Internal Medicine / Jan-mar 2015 / Vol 3 | Issue 1 , 2022 .

[106]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[107]  J. DeGregori,et al.  Stochastic modeling indicates that aging and somatic evolution in the hematopoietic system are driven by non-cell-autonomous processes , 2014, Aging.

[108]  V. Weaver,et al.  The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.

[109]  P. Linton,et al.  Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart. , 2014, Immunology letters.

[110]  Christopher S. Chen,et al.  Long Range Force Transmission in Fibrous Matrices Enabled by Tension-Driven Alignment of Fibers , 2014, bioRxiv.

[111]  M. Clynes,et al.  Bone Disease in Multiple Myeloma: Pathophysiology and Management , 2014, Cancer growth and metastasis.

[112]  A. Ruíz-Sauri,et al.  Age‐related dermal collagen changes during development, maturation and ageing – a morphometric and comparative study , 2014, Journal of anatomy.

[113]  C. Hajdu,et al.  Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. , 2014, The Journal of clinical investigation.

[114]  J. Ibrahim,et al.  Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. , 2014, Journal of the National Cancer Institute.

[115]  R. Jain,et al.  Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal‐derived factor 1 alpha/C‐X‐C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice , 2014, Hepatology.

[116]  Jessie C. Jeyapalan,et al.  A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging , 2014, AGE.

[117]  M. Narita,et al.  Cellular senescence and its effector programs , 2014, Genes & development.

[118]  A. Anderson,et al.  Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. , 2013, Cancer research.

[119]  J. Sharpe,et al.  Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning , 2013, Cell.

[120]  A. Rodríguez-Baeza,et al.  Programmed Cell Senescence during Mammalian Embryonic Development , 2013, Cell.

[121]  A. Chambery,et al.  Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells , 2013, Cell Death and Disease.

[122]  D. Palmer.  The Effect of Age on Thymic Function , 2013, Front. Immunol..

[123]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[124]  C. Franceschi,et al.  MicroRNAs linking inflamm-aging, cellular senescence and cancer , 2013, Ageing Research Reviews.

[125]  Y. DeClerck,et al.  Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. , 2013, Cancer research.

[126]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[127]  M. Grounds,et al.  Targeting macrophages rescues age‐related immune deficiencies in C57BL/6J geriatric mice , 2013, Aging cell.

[128]  E. Nevo,et al.  High molecular weight hyaluronan mediates the cancer resistance of the naked mole-rat , 2013, Nature.

[129]  C. Verschoor,et al.  Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer , 2013, Journal of leukocyte biology.

[130]  J. Campisi.  Aging, cellular senescence, and cancer. , 2013, Annual review of physiology.

[131]  Claudio Franceschi,et al.  Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging , 2012, Mechanisms of Ageing and Development.

[132]  S. Weintraub,et al.  Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence , 2012, Proceedings of the National Academy of Sciences.

[133]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[134]  P. Muti,et al.  SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells , 2012, Oncogene.

[135]  S. Albelda,et al.  Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.

[136]  S. Stewart,et al.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. , 2012, Cancer research.

[137]  Suzanne R. Thibodeaux,et al.  Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. , 2012, Cancer research.

[138]  D. Nelson,et al.  Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses , 2012, Cancer Immunology, Immunotherapy.

[139]  K. Delman,et al.  Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma , 2012, International journal of surgical oncology.

[140]  M. Morre,et al.  Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival , 2012, Targeted Oncology.

[141]  Steven A. Carr,et al.  The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.

[142]  F. Sotgia,et al.  Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth , 2011, Cell cycle.

[143]  J. Pfeilschifter,et al.  Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21 , 2011, Science Signaling.

[144]  N. LeBrasseur,et al.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.

[145]  D. Schadendorf,et al.  Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model , 2011, Proceedings of the National Academy of Sciences.

[146]  F. Sotgia,et al.  Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. , 2011, The international journal of biochemistry & cell biology.

[147]  E. Cukierman,et al.  FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.

[148]  J. Chung,et al.  Intrinsic aging- and photoaging-dependent level changes of glycosaminoglycans and their correlation with water content in human skin. , 2011, Journal of dermatological science.

[149]  A. Pera,et al.  Immunosenescence of Human Natural Killer Cells , 2011, Journal of Innate Immunity.

[150]  R. Scolyer,et al.  BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site , 2011, Pigment cell & melanoma research.

[151]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[152]  Thomas R. Cox,et al.  Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer , 2011, Disease Models & Mechanisms.

[153]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[154]  J. Campisi,et al.  Four faces of cellular senescence , 2011, The Journal of cell biology.

[155]  R. Daynes,et al.  A Role for Immature Myeloid Cells in Immune Senescence , 2011, The Journal of Immunology.

[156]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[157]  C. Chougnet,et al.  Partial restoration of T‐cell function in aged mice by in vitro blockade of the PD‐1/ PD‐L1 pathway , 2010, Aging cell.

[158]  Aristotelis Tsirigos,et al.  The autophagic tumor stroma model of cancer , 2010, Cell cycle.

[159]  Jie Zhou,et al.  Autophagy in cancer associated fibroblasts promotes tumor cell survival , 2010, Cell cycle.

[160]  Haidong Dong,et al.  B7-H1 Expression on Old CD8+ T Cells Negatively Regulates the Activation of Immune Responses in Aged Animals , 2010, The Journal of Immunology.

[161]  I. Jacobs,et al.  Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. , 2010, Neoplasia.

[162]  K. Chin,et al.  A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen , 2010, PloS one.

[163]  J. Campisi,et al.  The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.

[164]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[165]  Robert A. Gatenby,et al.  Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.

[166]  Y. Shimada,et al.  Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells , 2009, Experimental Gerontology.

[167]  A. Chang,et al.  FOXP3 defines regulatory T cells in human tumor and autoimmune disease. , 2009, Cancer research.

[168]  Y. Meng,et al.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models , 2009, Proceedings of the National Academy of Sciences.

[169]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[170]  Christian R. Gomez,et al.  Innate immunity and aging , 2008, Experimental Gerontology.

[171]  J. Macoska,et al.  The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. , 2008, Cytokine.

[172]  D. Peeper,et al.  Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network , 2008, Cell.

[173]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[174]  Mushtaq Ahmed,et al.  Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus , 2008, The Journal of experimental medicine.

[175]  Michael R. Green,et al.  Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.

[176]  W. Grizzle,et al.  Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice , 2007, Mechanisms of Ageing and Development.

[177]  N. Drela,et al.  Age‐related changes in the occurrence and characteristics of thymic CD4+ CD25+ T cells in mice , 2007, Immunology.

[178]  A. Cooke,et al.  An early age‐related increase in the frequency of CD4+ Foxp3+ cells in BDC2·5NOD mice , 2007, Immunology.

[179]  G. Fuh,et al.  Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells , 2007, Nature Biotechnology.

[180]  L. Stoltze,et al.  Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration , 2007, Journal of Neuroimmunology.

[181]  Yong Zhao,et al.  Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice , 2007, Journal of leukocyte biology.

[182]  P. Hornsby,et al.  Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.

[183]  Heike Knüpfer,et al.  Significance of interleukin-6 (IL-6) in breast cancer (review) , 2007, Breast Cancer Research and Treatment.

[184]  J. Lustgarten,et al.  High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged Animals1 , 2006, The Journal of Immunology.

[185]  J. Campisi,et al.  Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence* , 2006, Journal of Biological Chemistry.

[186]  R. Bernards,et al.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence , 2006, Nature Cell Biology.

[187]  J. Werner,et al.  Clinical patterns of metastasis , 2006, Cancer and Metastasis Reviews.

[188]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[189]  James Varani,et al.  Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. , 2006, The American journal of pathology.

[190]  P. Fink,et al.  Thymic output in aged mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[191]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[192]  Myriam Labalette,et al.  Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartment , 2006, Mechanisms of Ageing and Development.

[193]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[194]  C. Caruso,et al.  Impairment of gamma/delta T lymphocytes in elderly: implications for immunosenescence , 2004, Experimental Gerontology.

[195]  T. Randall,et al.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[196]  L. Rink,et al.  Neutrophil immunity of the elderly , 2003, Mechanisms of Ageing and Development.

[197]  Donald R Schwartz,et al.  Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. , 2003, Cancer cell.

[198]  J. Foekens,et al.  Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression , 2003, Thrombosis and Haemostasis.

[199]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[200]  James Varani,et al.  Mechanisms of photoaging and chronological skin aging. , 2002, Archives of dermatology.

[201]  J. Lagarde,et al.  Skin ageing: changes of physical properties of human skin in vivo , 2001, International journal of cosmetic science.

[202]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[203]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[204]  V. Kosma,et al.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. , 2000, The American journal of pathology.

[205]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[206]  D. Wynford‐Thomas.  Cellular senescence and cancer , 1999, The Journal of pathology.

[207]  W. Klapper,et al.  Longevity of lobsters is linked to ubiquitous telomerase expression , 1998, FEBS letters.

[208]  Wolfram Klapper,et al.  Telomerase activity in ‘immortal’ fish 1 , 1998 .

[209]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[210]  Allan Bradley,et al.  Increased bone formation in osteocalcin-deficient mice , 1996, Nature.

[211]  G. Zeng,et al.  Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. , 1996, Experimental cell research.

[212]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[213]  D. Keene,et al.  The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[214]  M. Nimni,et al.  Crosslinked CNBr-activated hyaluronan-collagen matrices: effects on fibroblast contraction. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[215]  M. Dean,et al.  An N-terminal peptide from link protein is rapidly degraded by chondrocytes, monocytes and B cells. , 1993, European journal of biochemistry.

[216]  A. J. Millis,et al.  Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. , 1992, Experimental cell research.

[217]  J. R. Smith,et al.  Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.

[218]  J. Davidson,et al.  Elastin production in human skin fibroblast cultures and its decline with age. , 1986, The Journal of investigative dermatology.

[219]  John N. Hutchinson,et al.  Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. , 2019, Cancer discovery.

[220]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[221]  J. Campisi,et al.  Cell senescence: role in aging and age-related diseases. , 2014, Interdisciplinary topics in gerontology.

[222]  A. Noel,et al.  Targeting the tumor microenvironment for cancer therapy. , 2013, Clinical chemistry.

[223]  O. Vasil’eva,et al.  [Age-related changes in the number and proliferation of fibroblasts in the human skin]. , 2011, Advances in gerontology = Uspekhi gerontologii.

[224]  H. Rehrauer,et al.  Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. , 2011, European journal of cancer.

[225]  H. Cottier,et al.  Regional differences in renewal rates of fibroblasts in young adult female mice , 2004, Cell and Tissue Research.

[226]  W. Dalton,et al.  Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies , 2004, Cancer and Metastasis Reviews.

[227]  W. Klapper,et al.  Telomerase activity in 'immortal' fish. , 1998, FEBS letters.

[228]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[229]  R. Behnke,et al.  CHANGES WITH ADVANCING AGE IN THE CELL POPULATION OF HUMAN DERMIS. , 1964, Gerontologia.